Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trang T Ly

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Diabetes Care|June 8, 2021
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 DiabetesSue A Brown, Gregory P Forlenza, Bruce W Bode, et al.
Diabetes Technology & Therapeutics|December 16, 2020
First Outpatient Evaluation of a Tubeless Automated Insulin Delivery System with Customizable Glucose Targets in Children and Adults with Type 1 DiabetesGregory P Forlenza, Bruce A Buckingham, Sue A Brown, et al.
Diabetes Care|May 22, 2016
Multinational Home Use of Closed-Loop Control Is Safe and EffectiveStacey M Anderson, Dan Raghinaru, Jordan E Pinsker, et al.
JAMA Network Open|February 14, 2025
Automated Insulin Delivery in Adults With Type 2 Diabetes: A Nonrandomized Clinical TrialFrancisco J Pasquel, Georgia M Davis, David M Huffman, et al.
Diabetes Care|June 9, 2022
Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical TrialJennifer L Sherr, Bruce W Bode, Gregory P Forlenza, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Diabetes Care|June 8, 2021
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 DiabetesSue A Brown, Gregory P Forlenza, Bruce W Bode, et al.
Diabetes Technology & Therapeutics|December 16, 2020
First Outpatient Evaluation of a Tubeless Automated Insulin Delivery System with Customizable Glucose Targets in Children and Adults with Type 1 DiabetesGregory P Forlenza, Bruce A Buckingham, Sue A Brown, et al.
Diabetes Care|May 22, 2016
Multinational Home Use of Closed-Loop Control Is Safe and EffectiveStacey M Anderson, Dan Raghinaru, Jordan E Pinsker, et al.
JAMA Network Open|February 14, 2025
Automated Insulin Delivery in Adults With Type 2 Diabetes: A Nonrandomized Clinical TrialFrancisco J Pasquel, Georgia M Davis, David M Huffman, et al.
Diabetes Care|June 9, 2022
Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical TrialJennifer L Sherr, Bruce W Bode, Gregory P Forlenza, et al.
Pageof 7